Empfohlen
Empfohlen
Weitere ähnliche Inhalte
Was ist angesagt?
Was ist angesagt? (20)
Ähnlich wie Bio2016 Invest NI Breakfast Presentation 8th June
Ähnlich wie Bio2016 Invest NI Breakfast Presentation 8th June (20)
Kürzlich hochgeladen
Kürzlich hochgeladen (20)
Bio2016 Invest NI Breakfast Presentation 8th June
- 2. Northern Ireland Collaborative, Commercialised, Connected Barry Henderson Business Development Director Invest Northern Ireland
- 3. Why Northern Ireland? Access to and Availability of Talent Excellent Scientific R&D Base High Quality Clinical Data and Materials Excellent Physical and Communications Infrastructure Innovation-friendly Healthcare System
- 4. A highly educated and skilled workforce 52,000 undergraduates & postgraduates B.Sc. & M.Sc. Stratified Medicine 13,000 studying life & health sciences subjects
- 5. Top 10 in the UK for Bioscience Research Clinical specialisms Oncology Inflammation Respiratory Cardiology Dementia Diabetes Vision Obesity Enablers Precision Medicine Diagnostics Clinical Trials Big Data World-class Scientific Capability
- 6. High Quality Patient Data & Clinical Materials NI Health Service • 5 Trusts, 66,000 staff, 10 Acute hospitals and also 6 Enhanced/local hospitals • Fully integrated health care provision Highly Regulated Environment and Support • Wellcome Trust- Woolfson Foundation Clinical Research Facility • NI Cancer Trials Centre (NICT) & Network (NICTN) • Clinical Research Networks integrate with UK wide Clinical Research Networks • Clinical Translational Research and Innovation Centre Access to Data and Clinical Samples • NI Electronic Care Record (NIECR) • Honest Broker Service – Northern Ireland in lead position for Big Data • NI BioBank - NHS tissue archives, unique tissue microarrays, DNA libraries • International Health Analytics Centre
- 7. Innovation-friendly Healthcare System Healthcare Innovation ‘Living Lab’ Small and complete demographic – 1.8m people ‘Closed Loop System’ – ideal conditions for Public/Private collaboration Microcosm for NHS and social services across the UK Global opportunities for Northern Ireland health innovations Market access to NHS, largest single healthcare market in the world – 72m patients Healthcare Innovation Programmes Small Business Research Initiative (SBRI): Current calls: - Support for stroke survivors - Medicines management in domiciliary care Previous calls: - Medicines optimisation - Stratified medicine - Assisted living - Paediatric improved - diagnostics/ non-invasive technologies Precision Medicine Testbed: - Validation & adoption Industry focused Programmes Support Infrastructure Precision Medicine Catapult (CLIA Ready) Clinical Translational Research & Innovation Centre Connected Health Innovation Centre HSC Innovations NI Connected Health Ecosystem
- 8. Support & Infrastructure Attractive tax regime • Corporation tax rate lowering to 12.5% in April 2018 Support • Invest NI financial assistance can include – grants towards salaries, pre- & post- employment training and R&D • Access to UK’s R&D tax credits and patent box • Invest NI connect & signpost to potential collaborators & experts including academia, business, clinical & regulatory $ World-class physical and communications infrastructure • Fast reliable road, rail, air and telecoms links between Northern Ireland, North America and Europe
- 9. Thank you Barry Henderson Invest Northern Ireland Boston Invest Northern Ireland - Americas@Invest NI_USA InvestNI.com
- 10. ‘Northern Ireland, Leading the way in Life & Health Science’ Panel Session - Dr Robert Ladner, CEO - CV6 Therapeutics - Gareth Maguire, Director of Business Development - Almac - Joel McComb, CEO - Biospyder Technologies - Prof David Waugh, Director - Centre for Cancer Research & Cell Biology - Queen’s University Belfast Barry Henderson Business Development Director Invest Northern Ireland
Hinweis der Redaktion
- Northern Ireland Intro Invest Northern Ireland works with companies seeking to grow and service their European Market, reduce costs or access specific expertise to further develop their products. Northern Ireland hosts a thriving life science sector, key enabling infrastructure and strengths across a number of specific disease areas and technology domains. Generous government support and a lower incoming taxation rate make Northern Ireland very attractive proposition.
- NI has a highly educated and skilled population with 52,000 under/postgraduates with > 13,000 studying life and health science subjects. NI is home to the UK’s first B.Sc and M.Sc courses in Stratified Medicine. Recent ‘FDI Benchmark’ comparison data for a 50 person life science R&D centre indicates that salary costs in NI would be >50% lower than Boston.
- Ulster University & Queen’s University Belfast rank among the top 10 in UK for bioscience research. A buoyant local sector has seen investment from public and private sector increase to $0.5 billion in last 5 years. NI has a key strength in Precision Medicine which couples academic and clinical specialisms in Oncology, Inflammation, Respiratory, Cardiology, Dementia, Diabetes, Vision and Obesity to core capabilities, technologies and infrastructure relating to Diagnostics, Clinical Trials and Big Data.
- High Quality Patient Data and Clinical Materials NI hosts key enabling Clinical Research Infrastructure which is highly regulated and scalable including: NI Cancer Trials Centre (NICT) Wellcome Trust- Woolfson Foundation Clinical Research Facility, NI Cancer Trials Network (NICTN) Clinical Research Networks integrate with UK wide Clinical Research Networks The International Health Analytics Centre & Honest Broker Service position NI in lead position for Big Data with NI BioBank providing access to NHS tissue archives, unique tissue microarrays, DNA libraries etc.
- NI has a population base of 1.8m each of whom benefit from fully integrated health care provision utilizing the NI Electronic Care Record (NIECR), a unique resource in the UK. It represents a single source of patient data including laboratory test results, x-rays, full patient documentation and details of conditions including diabetes and related co-morbid disorders enabling information to be easily shared across the entire patient journey. Precision Medicine Catapult- Cancer Diagnostics Dx & eHealth: drive innovation & industry growth, early test-bedding, adoption, reimbursement (CLIA Ready)
- Infrastructure & Support - NI’s new Corporation Tax (April 2018 Rate: 12.5%) and various R&D, pre-employment, training and salary grants Invest Northern Ireland offer, the region has become very attractive to US companies. - Market Access to the National Health Service, largest single healthcare market in world with 72m patients, now enabled via the Small Business Research Initiative